Check the latest share price of Beryl Drugs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
BSE
Get live Beryl Drugs Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 2.2 % |
3 Month Return | -16.19 % |
1 Year Return | -44.94 % |
3 Year Return | + 116.23 % |
5 Year Return | + 249.3 % |
Market Stats | |
Previous Close | ₹19.14 |
Open | ₹18.20 |
Volume | 19.30K |
Upper Circuit | ₹20.09 |
Lower Circuit | ₹18.19 |
Check Beryl Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹10.13 Cr
Return on Equity (ROE)
9.07
PE Ratio (TTM)
0Return on capital employed (ROCE)
11.38
Beta (LTM)
0.45
P/B Ratio
1.67
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-142.86
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Investing in Beryl Drugs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Beryl Drugs Ltd or 524606 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Beryl Drugs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Beryl Drugs Ltd with just a few clicks!
Get the annual and quarterly financial summary of Beryl Drugs Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Beryl Drugs Ltd.
Beryl Drugs Ltd’s net profit jumped 142.86% since last year same period to ₹0.15Cr in the Q4 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 200% jump in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Beryl Drugs Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 26.38% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 73.62% | 0.00 | |
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Beryl Drugs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 10.13 | 49.86% | 0.69 | -1 | 26 | |
NA | 6.24 | 5.19% | 5.69 | NA | NA | |
NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 90.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 26.38% of holdings in Mar 2025 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 73.62% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 14.8%
Price Dip
In the last 3 months, Beryl Drugs stock has moved down by -16.2%
Organisation | Beryl Drugs Ltd |
Industry | Pharmaceuticals |
CEO | Sudhir Sethi |
E-voting on shares | Click here to vote |
Beryl Drugs Ltd share price today stands at ₹20.09, Open: ₹18.2, Previous Close: ₹19.14, High: ₹20.09, Low: ₹18.2, 52 Week High: ₹46, 52 Week Low: ₹17.35.
Today's traded volume of Beryl Drugs Ltd is 19.30K. Which means that 19.30K shares of Beryl Drugs Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Beryl Drugs Ltd is ₹10.13 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Beryl Drugs Ltd’s 52 week high is ₹46 and 52 week low is ₹17.35. The current share price of Beryl Drugs Ltd is ₹20.09, which is -56.33% down from its 52 week high and 15.79% up from its 52 week low.